Nalaganje...

Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma

Systemic chemotherapy has remained the traditional treatment for metastatic non-small-cell lung carcinoma (NSCLC), enhancing survival rate at 1 year to 29%. The median survival had plateaued at around 10 months until early 2008, and in an attempt to enhance survival in advanced disease, maintenance...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Furrukh, Muhammad, Burney, Ikram A., Kumar, Shiyam, Zahid, Khwaja F., Al-Moundhri, Mansour
Format: Artigo
Jezik:Inglês
Izdano: Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616797/
https://ncbi.nlm.nih.gov/pubmed/23573377
Oznake: Označite
Brez oznak, prvi označite!